Mobility impairment is associated with greater mortality, morbidity, cognitive decline, and dementia, making it a major health care priority and central to physical, mental, and social well-being. That’s why many now consider real-world walking speed to be the 6th vital sign.
But despite its importance, it has been difficult to generate regulatory-acceptable endpoint measures for use in clinical trials, real-world assessment of mobility, and improved patient treatment.
That is, until now. Kristen Sowalsky, PhD, the Director, Clinical Science and Consulting for Wearables and Digital Biomarkers at ERT, will share the latest advancements in wearable technologies, revealing how they provide new opportunities to objectively quantify patient functional mobility by obtaining precision motion data in clinical and real-world settings. Her DPharm 2021 session will focus on:
- Why accurately measuring mobility is so important for patient outcomes
- How best to measure specific mobility endpoints that are both sensitive to change and meaningful to patient quality of life
- An update on the Mobilise-D initiative, in which digital mobility outcomes (DMO’s) are being established and validated
Please fill out the following form to watch this webinar.
Kristen Sowalsky, PhD, DC
Director, Clinical Science and Consulting, Wearables & Digital Biomarkers, ERT
Dr. Sowalsky leads the science advisory services for Wearables & Digital Biomarkers at ERT. With an advanced background in applied neuromechanics, kinesiology, and exercise science, including 6 years as a provider in clinical practice, she consults with clinicians, researchers, and product technologists providing scientific evidence and advice to sponsors on meeting clinical trial study objectives related to:
- Human Movement, Neuroscience, Movement Disorders, Gait & Balance, Physical Therapy, Rehabilitation, Biomechanics, Physiology
- Movement-Specific Protocol Development
- Wearables & Digital Biomarkers Instrumented Test Selection, Configuration, Customization, and Implementation
- Digital Endpoint Selection and Evaluation
Dr. Sowalsky’s academic achievements include a B.S. in kinesiology and exercise science from Appalachian State University, Doctor of Chiropractic from Logan University, and a Ph.D., applied neuromechanics, from the University of Florida. Passionate about improving the lives of patients and their families, Dr. Sowalsky continues to build the body of evidence for precision motion monitoring measures to capture meaningful digital mobility outcomes to inform therapeutic innovation and development.